Amplitude Fellowship Class of 2027 is expanding to welcome Saudi PhD candidates, postdoctoral researchers, and MDs
6 successful cohorts in Canada and over 40 PhD candidates, postdocs and MD Fellows trained
Hands-on, full-time training over three months to learn how to turn bold scientific questions into the next generation of biotech companies
MONTRÉAL, Canada, November 11, 2026 — Amplitude Ventures today announced the expansion of its Fellowship program through a new Saudi pathway developed in collaboration with the Canada–Saudi Biotech Corridor. Beginning with the Class of 2027, select Saudi scientists will be eligible to participate in the Amplitude Fellowship, marking the program’s first dedicated international pathway. The initiative reflects a shared effort to harness growing Canada–Saudi biotechnology ties and talent through Pre-Amp, Amplitude’s venture creation studio.
A proven model for scientific entrepreneurship
The Amplitude Fellowship is a fully funded, in-person summer program run by Amplitude Ventures and its venture creation studio, Pre-Amp. Amplitude Fellows spend the summer in Montréal working alongside the Pre-Amp team, moving through cycles of landscaping, consulting, and white-space exploration in scientific areas. Along the way, they learn to think like venture creators: identifying unmet needs, framing venture hypotheses, and testing those hypotheses against scientific and commercial evidence.
The program has a strong track record. Since its inception in 2021, more than 40 Fellows have graduated from the Fellowship. Graduates are now in key roles in the life sciences industry across North America, including at Amplitude portfolio companies and the firm’s new company creations such as Stereo Biotherapeutics and RIME Therapeutics.
The Fellowship’s Class of 2026 drew a record number of applications from across Canada and beyond, and the Saudi pathway aims to build on that international reach.
“Every great biotech company starts with a builder who knows which scientific questions are worth asking. The Fellowship teaches scientists to ask those questions well, and to test whether the answers could become a company.”
— Michael Mee, Managing Director, Pre-Amp
A Canada–Saudi pathway for venture creation
Building on the rich history of academic scientific exchange between Canada and the Kingdom of Saudi Arabia, the new pathway is a practical outcome of collaboration between Amplitude Ventures and the Canada–Saudi Biotech Corridor. The Saudi pathway is shared with universities and national research institutions across the Kingdom, with King Abdulaziz University among the first institutions to participate. Working directly with the Pre-Amp team and Amplitude’s network of investors and company builders, Saudi Fellows will learn to identify unmet needs, evaluate scientific and commercial evidence, and shape new biotechnology ventures. The initiative is intended to deepen ties between Canadian and Saudi scientists, expand opportunities for collaboration in both countries, and contribute to Saudi Arabia’s growing biotechnology ecosystem.
“At King Abdulaziz University, we recognize the importance of developing research talent and translating scientific knowledge into practical impact. Such initiatives contribute to advancing the Kingdom’s ambitions in biotechnology and the knowledge economy.”
— Dr. Tareef Al-Ama, President, King Abdulaziz University
The Canada–Saudi Biotech Corridor helped develop and advance the Saudi pathway as part of its Investment & Biotech Acceleration Pillar, working with Amplitude Ventures to connect the Fellowship with Saudi universities, research institutions, and prospective candidates. The initiative reflects the Corridor’s broader mission of turning bilateral relationships into practical platforms for talent development, venture creation, investment, and biotechnology commercialization.
“Saudi Arabia’s National Biotechnology Strategy calls for building the talent and commercialization capabilities needed to grow a globally competitive biotechnology ecosystem. This partnership is a practical example of the Canada–Saudi Biotech Corridor turning that ambition into action.”
— Dr. Abdulelah AlHawsawi, Saudi Co-Chair, Canada–Saudi Biotech Corridor
How to get involved
Applications for the Amplitude Fellowship Class of 2027 are now open until January 17, 2027, to PhD candidates, postdoctoral researchers, and MDs in the life sciences.
Learn more at amplitudevc.com/en/fellowship and find upcoming virtual information sessions here. All interested candidates are encouraged to apply.
-30-
About Amplitude Ventures
Amplitude Ventures invests in precision medicine companies that operate at the intersection of biology and AI. Investing globally with strong Canadian roots, Amplitude is on a mission to transform people’s lives by creating, building, and scaling companies that deliver groundbreaking treatments to patients around the world. Through Pre-Amp, its venture creation studio, Amplitude builds companies from scratch alongside leading scientists, clinicians, and entrepreneurs.
The Amplitude model assembles world-class management teams, provides the depth of capital to scale globally, and drives portfolio companies to breakout potential. This approach has produced over $6 billion of growth in company value and brought new treatments to market.
About the Canada–Saudi Biotech Corridor
The Canada–Saudi Biotech Corridor is a bilateral platform connecting the biotechnology ecosystems of Canada and the Kingdom of Saudi Arabia to turn international collaboration into practical programs, partnerships, investment, and venture creation. Launched in Riyadh in February 2026, the Corridor brings together leaders from academia, industry, investment, healthcare, and government around four core pillars: Academic & Technology Transfer; Investment & Acceleration; Genomics & Precision Medicine; and Clinical Trials & Biomanufacturing. The Corridor focuses on building durable institutional partnerships, developing talent, strengthening commercialization pathways, and connecting scientific and clinical capabilities with experienced operators and capital across both countries.
Contacts
Amplitude Ventures
Karen N. Li
Manager, Marketing and Communications, Amplitude Ventures
kli@amplitudevc.com
Bharat Srinivasa, PhD
Partner, Amplitude Ventures
514-781-1625
bsrinivasa@amplitudevc.com
Canada–Saudi Biotech Corridor Contact – Kingdom of Saudi Arabia
Dr. Abdulelah AlHawsawi
Co-chair, Kingdom of Saudi Arabia
Canada–Saudi Biotech Corridor
a.alhawsawi@novogenomics.sa
